Ambey Laboratories Board of Directors
Get the latest insights into the leadership at Ambey Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mrs. Sarina Gupta | Whole Time Director |
| Mrs. Rishita Gupta | Non Executive Director |
| Mr. Sandeep Bansal | Non Executive Director |
| Mr. Abdul Quadir | Ind. Non-Executive Director |
| Ms. Roni Soni | Ind. Non-Executive Director |
Ambey Laboratories Share price
AMBEY
42.35
0.40 (-0.94%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:48 IST
BUYSELL
Today's High
43.90
Today's Low
42.35
52 Week Low
31.85
52 Week High
78.95
The current prices are delayed, login to your account for live prices
LoginAmbey Laboratories FAQs
The board at Ambey Laboratories consists of experienced professionals, including Mrs. Sarina Gupta , Mrs. Rishita Gupta , and others, overseeing the company’s strategic and corporate governance.
Directors at Ambey Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mrs. Sarina Gupta is the current chairman at Ambey Laboratories.
Executive directors at Ambey Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Ambey Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Ambey Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.